Dendritic cells transduced with protein antigens induce cytotoxic lymphocytes and elicit antitumor immunity.
about
Co-administration of a DNA vaccine encoding the prostate specific membrane antigen and CpG oligodeoxynucleotides suppresses tumor growthUse of Cell-Penetrating Peptides in Dendritic Cell-Based VaccinationTat mammaglobin fusion protein transduced dendritic cells stimulate mammaglobin-specific CD4 and CD8 T cells.Dendritic cell-mediated-immunization with xenogenic PrP and adenoviral vectors breaks tolerance and prolongs mice survival against experimental scrapie.Comparative measurement of cell-mediated immune responses of swine to the M and N proteins of porcine reproductive and respiratory syndrome virus.Dendritic cells transfected with scFv from Mab 7.B12 mimicking original antigen gp43 induces protection against experimental Paracoccidioidomycosis.In vivo delivery of antigens by adenovirus dodecahedron induces cellular and humoral immune responses to elicit antitumor immunity.A lipopeptide facilitate induction of Mycobacterium leprae killing in host cells.Genetically modified dendritic cells--a new, promising cancer treatment strategy?Lipid binding activities of flax rust AvrM and AvrL567 effectorsTherapeutic vaccination with tumor cells that engage CD137.Intracellular cargo delivery using tat peptide and derivatives.Targeting plasmid-encoded proteins to the antigen presentation pathways.Transactivating transcriptional activator-mediated drug delivery.Dendritic cells strongly boost the antitumor activity of adoptively transferred T cells in vivo.The taming of the cell penetrating domain of the HIV Tat: myths and realities.Targeted pharmaceutical nanocarriers for cancer therapy and imagingPotential targets for pancreatic cancer immunotherapeutics.Current status of multiple antigen-presenting peptide vaccine systems: Application of organic and inorganic nanoparticles.Enhancing Antitumor Immune Responses by Optimized Combinations of Cell-penetrating Peptide-based Vaccines and AdjuvantsVaccine delivery by penetratin: mechanism of antigen presentation by dendritic cells.Enhanced cellular uptake of a TAT-conjugated peptide inhibitor targeting the polo-box domain of polo-like kinase 1.Protection and immunological study on two tetraspanin-derived vaccine candidates against schistosomiasis japonicum.Design, synthesis and biological activity of cell-penetrating peptide-modified octreotide analogs.The Tat-conjugated N-terminal region of mucin antigen 1 (MUC1) induces protective immunity against MUC1-expressing tumours.Protective anti-tumour immune responses by murine dendritic cells pulsed with recombinant Tat-carcinoembryonic antigen derived from Escherichia coli.Anti-tumor activity of Acinetobacter baumannii outer membrane protein A on dendritic cell-based immunotherapy against murine melanoma.Comparison of recombinant adenovirus and synthetic peptide for DC-based melanoma vaccination.Cell entry of arginine-rich peptides is independent of endocytosis.Protein transduction: generation of full-length transducible proteins using the TAT system.Site-specific conjugation of HIV-1 tat peptides to IgG: a potential route to construct radioimmunoconjugates for targeting intracellular and nuclear epitopes in cancer.Addition of TAT protein transduction domain and GrpE to human p53 provides soluble fusion proteins that can be transduced into dendritic cells and elicit p53-specific T-cell responses in HLA-A*0201 transgenic mice.Human cytomegalovirus protein pp65: an efficient protein carrier system into human dendritic cells.The impact of electrical charge on the viability and physiology of dendritic cells.Transduction of cell-penetrating peptides into induced pluripotent stem cells.Effective induction of anti-melanoma immunity following genetic vaccination with synthetic mRNA coding for the fusion protein EGFP.TRP2.Dendritic cells fused with core binding factor-beta positive acute myeloid leukaemia blast cells induce activation of cytotoxic lymphocytes.Mechanistic insights into the efficacy of cell penetrating peptide-based cancer vaccines.Enhanced antitumour immunity by combined use of temozolomide and TAT-survivin pulsed dendritic cells in a murine glioma.Penetratin tandemly linked to a CTL peptide induces anti-tumour T-cell responses via a cross-presentation pathway
P2860
Q24794166-38BA5AC0-8217-4860-9EA8-38E12F1047C4Q26764861-B30366BE-7796-4470-9065-5032C7703EDBQ33216945-4083D764-D70A-4B86-BBA5-00B34DC6A591Q33419380-703DF4B4-659D-4BBD-BBA0-A379B0DB5460Q33768736-2BB5F410-7333-485B-A81C-924A34930CF0Q33797988-125B9140-D046-4CBB-8B74-0C3F4C2B6C6DQ33931622-DEAD0AB2-B9B1-4717-9AC3-1F104B92573FQ34088234-E04DA242-791E-4E07-B419-68D175A4C69EQ35040829-D0A1C245-DA92-4D39-A9A2-6D29D25FA3BCQ35046089-DD051ABE-7C05-40C2-A656-B78B1B8062BEQ35071688-CBC941A0-A2D6-41B5-98FA-83E1FA96992DQ35574584-4C47D0D2-E3CF-4C58-AAA6-BCB39DC50E06Q35826370-9CA3B49F-D3A5-4CF0-9A8F-9D1A87632B08Q36409033-C2888F7C-DC2A-46FA-AA8B-F1AB4221C471Q36456769-3CC0EC7D-ECCC-40FA-84C3-EF5391C75876Q36695464-108A1EAE-3919-406A-AE9F-566294EF1178Q36871933-A1742B5F-B8D8-48B7-9287-FE9EE6B5122AQ37861220-95C85E84-68D6-4377-BA74-96A8EE761ACEQ37921384-F245627C-312E-4F2E-9E52-EB24F21B7398Q38759934-1100C187-739B-406F-8307-20D8FFB80CCEQ38872440-28E6733A-8D68-420B-8E87-7D420FC40C8CQ38963387-16E319D8-E73B-41B9-BCF0-D863A25D4EA7Q39758956-E69C81C2-70E7-455E-9873-F33CAC2AEFF4Q39762699-0BC07B0C-F9FE-42BA-83A4-FCDEB07E29DBQ39802340-423448E2-1602-4B09-9E4E-376C426E6538Q39816081-8E95642D-3574-41C7-A8E2-F3CB0B346B3EQ39973274-DD1FDC2C-77E4-4F33-9FC6-38F8DC4B7671Q40390484-A21AAF43-B9AA-4D97-93DF-7B6CA6D85DBBQ42117504-707AC60D-E3A5-4148-ADB1-5A38878B5534Q44235152-7FC89EA1-3ED8-4349-BA06-03CEF81B6B33Q44472217-C7014825-C110-4E3F-B97A-28153CAD54C3Q44960269-B78E51BF-AB27-4C1A-853E-A03FF168C79FQ45873436-3B6A1E2F-8199-4AFD-AEFD-2F5BC31E16D5Q46777207-F5F8E212-642D-41AB-B808-02052AFBD590Q50572161-9A772773-3A08-45D2-AC27-CB49CAB6B871Q50756622-59EEE033-DE1E-42EF-A223-BA94BE4565E0Q51998821-ED176A84-CC5E-4A1D-8D5F-F51DC8174538Q52672798-85E63835-D187-4BBA-B907-2A2104D742DBQ55467906-A7CEFCB9-53D2-4FFF-935F-41F619E8A0A3Q57594290-E123C22A-17E1-461D-A0CF-4EA5BFD30852
P2860
Dendritic cells transduced with protein antigens induce cytotoxic lymphocytes and elicit antitumor immunity.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Dendritic cells transduced wit ...... and elicit antitumor immunity.
@en
Dendritic cells transduced wit ...... and elicit antitumor immunity.
@nl
type
label
Dendritic cells transduced wit ...... and elicit antitumor immunity.
@en
Dendritic cells transduced wit ...... and elicit antitumor immunity.
@nl
prefLabel
Dendritic cells transduced wit ...... and elicit antitumor immunity.
@en
Dendritic cells transduced wit ...... and elicit antitumor immunity.
@nl
P1476
Dendritic cells transduced wit ...... and elicit antitumor immunity.
@en
P2093
Mark C Udey
Naotaka Shibagaki
P304
P356
10.4049/JIMMUNOL.168.5.2393
P407
P577
2002-03-01T00:00:00Z